Clinical outcome of acute and chronic hepatitis delta over time: A long-term follow-up study

Journal of Viral Hepatitis

Volumn 18, Issue 6, 2011, Pages 434-442

  Buti, M ^a,b   Homs, M ^a   Rodriguez Frias, F ^a,b   Funalleras, G ^b   Jardi R ^a,b   Sauleda, S ^a,c   Tabernero, D ^a   Schaper, M ^a   Esteban, R ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c Transfusion Safety Laboratory   (Spain)

Author keywords

hepatitis B and D coinfection; hepatitis delta superinfection

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS DELTA ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ARTICLE; DECOMPENSATED LIVER CIRRHOSIS; DELTA AGENT HEPATITIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEPATITIS C; HEPATITIS DELTA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SUPERINFECTION;

ACUTE DISEASE; ADOLESCENT; ADULT; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; DISEASE OUTBREAKS; DRUG USERS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HIV; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RNA, VIRAL; SUPERINFECTION; YOUNG ADULT;

EID: 79955445363     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01324.x     Document Type: Article

References (41)

1. Hoofnagle JH,. Type D (Delta) hepatitis. JAMA 1989; 262: 2995-2996.
2. Rizzetto M,. Hepatitis D: thirty years after. J Hepatol 2009; 50: 1043-1050.
3. Farci P,. Delta Hepatitis: an update. J Hepatol 2003; 39 (Suppl): S212-S219. (Pubitemid 37222675)
4. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (Delta/anti-Delta) associated to Hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977; 18: 997-1003. (Pubitemid 8263407)
5. World Health Organization. Hepatitis Delta, 2001. Available at: (accessed 4 May 2009).
6. Smedile A, Lavarini C, Farci P, et al. Epidemiologic patterns of infection with the Hepatitis B virus-associated Delta antigen in Italy. Am J Epidemiol 1983; 117: 223-229. (Pubitemid 13194926)
7. Sagnelli E, Stroffolini T, Mele A, et al. Chronic Hepatitis B in Italy: new features of an old disease - approaching the universal prevalence of Hepatitis B e antigen-negative cases and the eradication of Hepatitis D infection. Clin Infect Dis 2008; 46: 110-113. (Pubitemid 351263570)
8. Rosina F, Conoscitore P, Cuppone R, et al. Changing pattern of chronic Hepatitis D in Southern Europe. Gastroenterology 1999; 117: 161-166. (Pubitemid 29297633)
9. Gaeta GB, Stroffolini T, Chiaramonte M, et al. Chronic Hepatitis D: a vanishing disease? An Italian multicentric study. Hepatology 2000; 32: 824-827.
10. Rizzetto M, Verme G, Recchia S, et al. Chronic Hepatitis in carriers of Hepatitis B surface antigen, with intrahepatic expression of the Delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983; 98: 437-441. (Pubitemid 13116609)
11. Sagnelli E, Stroffolini T, Ascione A, et al. Decrease in HDV endemicity in Italy. J Hepatol 1997; 26: 20-24. (Pubitemid 27072600)
12. Mele A, Mariano A, Tosti M, et al. Acute Hepatitis Delta virus infection in Italy: incidence and risk factors after the introduction of the Universal Anti-Hepatitis B Vaccination Campaign. Clin Infect Dis 2007; 44: 17-24.
13. Flodgren E, Bengtsson S, Knutsson M, et al. Recent high incidence of fulminant Hepatitis in Samara, Russia: molecular analysis of prevailing Hepatitis B and D virus strains. J Clin Microbiol 2000; 38: 3311-3316.
14. Cross TJS, Rizzi P, Horner M, et al. The increasing prevalence of Hepatitis Delta virus (HDV) infection in South London. J Med Virol 2008; 80: 277-282.
15. Wedemeyer H, Heidrich B, Manns MP,. Hepatitis D virus infection-not a vanishing disease in Europe! Hepatology 2007; 45: 1331-1332. (Pubitemid 46775802)
16. Buti M, Esteban R, Jardi R, et al. Epidemiology of Delta infection in Spain. J Med Virol 1998; 26: 327-332.
17. Homann C, Krogsgaard K, Pedersen C, Andersson P, Nielsen JO., High incidence of hepatitis B infection and evolution of chronic hepatitis B infection in patients with advanced HIV infection. J Acquir Immune Defic Syndr 1991; 4: 416-420.
18. Navascués CA, Rodriguez M, Sotorrio N, et al. Epidemiology of Hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 1995; 90: 1981-1984.
19. Genesca J, Jardi R, Buti M, et al. Hepatitis B virus replication in acute hepatitis, acute hepatitis B virus-hepatitis delta virus coinfection and acute hepatitis delta superinfection. Hepatology 1987; 7: 569-572. (Pubitemid 17073166)
20. Buti M, Rodriguez-Frias F, Genesca J, et al. Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5'-monophosphate therapy in chronic hepatitis B. Liver 1993; 13: 136-140. (Pubitemid 23228708)
21. Jardi R, Rodriguez F, Buti M, et al. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay. J Viral Hepat 2001; 8: 465-471. (Pubitemid 35013573)
22. Rasshofer R, Buti M, Esteban R, Roggendorf M., Demonstration of hepatitis D virus RNA in patients with chronic hepatitis. J Infect Dis 1988; 157: 191-195. (Pubitemid 18037472)
23. Cotrina M, Buti M, Jardi R, et al. Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia). J Hepatol 1998; 2: 971-977. (Pubitemid 28275975)
24. Schaper M, Rodriguez-Frias F, Jardi R, et al. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol 2010; 52: 658-664.
25. Jardi R, Buti M, Cotrina M, Rodriguez F, Allende H, et al. Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection. Hepatology 1995; 21 (1): 25-29.
26. Hadziyannis SJ,. Decreasing prevalence of hepatitis D virus infection. J Gastroenterol Hepatol 1997; 12: 745-746. (Pubitemid 27512806)
27. Sheng WH, Hung CC, Kao JH, et al. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Clin Infect Dis 2007; 44: 988-995.
28. Salleras L, Domínguez A, Bruguera M, et al. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination. Vaccine 2007; 25: 8726-8731. (Pubitemid 350199596)
29. Manzardo C, Treviño B, Gõmez I, et al. Communicable diseases in the immigrant population attended to in a tropical medicine unit: epidemiological aspects and public health issues. Travel Med Infect Dis 2008; 6: 4-11.
30. Heidrich B, Deterding K, Tillmann HL, Raupach R, Manns MP, Wedemeyer H., Virological and clinical characteristics of delta hepatitis in Central Europe. J Viral Hepat 2009; 16: 883-894.
31. Balik I, Onul M, Tekeli E, Caredda F,. Epidemiology and clinical outcome of hepatitis D virus infection in Turkey. Eur J Epidemiol 1991; 7: 48-54.
32. Hadziyannis SJ, Papaioannou C, Alexopoulou A,. The role of the hepatitis delta virus in acute hepatitis and in chronic liver disease in Greece. Prog Clin Biol Res 1991; 364: 51-62.
33. Smedile A, Rizzetto M, Denniston KG, et al. Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay. Hepatology 1986; 6: 1297-1302. (Pubitemid 17221719)
34. Fattovich G, Giustina G, Christensen E, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000; 46: 420-426. (Pubitemid 30313398)
35. Soriano V, García-Samaniego J, Valencia E, Rodríguez-Rosado R, Muñoz F, González-Lahoz J., Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users. Eur J Epidemiol 1999; 15: 1-4. (Pubitemid 29093690)
36. Buti M, Jardi R, Allende H, Cotrina M, Esteban R, Guardia J., Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections? J Med Virol 1996; 49: 66-69. (Pubitemid 26167184)
37. Abiad H, Ramani R, Currie JB, Hershow RC., The natural history of Hepatitis D Virus infection in Illinois stat facilities for the developmentally disabled. Am J Gastroenterol 2001; 96: 534-540.
38. Liaw YF, Tsai SL, Sheen IS, et al. Clinical and virological course of chronic Hepatitis B virus infection with Hepatitis C and D virus markers. Am J Gastroenterol 1998; 93: 354-359.
39. Smedile A, Rosina F, Saracco G, et al. Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology 1991; 13: 413-416.
40. Niro GA, Smedile A, Ippolito A, et al. Outcome of chronic Hepatitis Delta in Italy: a long term cohort study. J Hepatol 2009; 50 (Suppl 1): S141.
41. Romeo R, Ninno ED, Rumi M, et al. A 28-year study of the course of hepatitis delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 2009; 136: 1629-1683.